205 related articles for article (PubMed ID: 9314544)
1. Induction of the angiogenic phenotype by Hox D3.
Boudreau N; Andrews C; Srebrow A; Ravanpay A; Cheresh DA
J Cell Biol; 1997 Oct; 139(1):257-64. PubMed ID: 9314544
[TBL] [Abstract][Full Text] [Related]
2. Homeobox B3 promotes capillary morphogenesis and angiogenesis.
Myers C; Charboneau A; Boudreau N
J Cell Biol; 2000 Jan; 148(2):343-51. PubMed ID: 10648567
[TBL] [Abstract][Full Text] [Related]
3. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis.
Boudreau NJ; Varner JA
J Biol Chem; 2004 Feb; 279(6):4862-8. PubMed ID: 14610084
[TBL] [Abstract][Full Text] [Related]
4. Pbx1 is required for Hox D3-mediated angiogenesis.
Charboneau A; East L; Mulholland N; Rohde M; Boudreau N
Angiogenesis; 2005; 8(4):289-96. PubMed ID: 16328158
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
[TBL] [Abstract][Full Text] [Related]
6. Sustained expression of homeobox D10 inhibits angiogenesis.
Myers C; Charboneau A; Cheung I; Hanks D; Boudreau N
Am J Pathol; 2002 Dec; 161(6):2099-109. PubMed ID: 12466126
[TBL] [Abstract][Full Text] [Related]
7. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3.
Oda N; Abe M; Sato Y
J Cell Physiol; 1999 Feb; 178(2):121-32. PubMed ID: 10048576
[TBL] [Abstract][Full Text] [Related]
8. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.
Jimi S; Ito K; Kohno K; Ono M; Kuwano M; Itagaki Y; Ishikawa H
Biochem Biophys Res Commun; 1995 Jun; 211(2):476-83. PubMed ID: 7540839
[TBL] [Abstract][Full Text] [Related]
9. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
10. Hox D3 expression in normal and impaired wound healing.
Uyeno LA; Newman-Keagle JA; Cheung I; Hunt TK; Young DM; Boudreau N
J Surg Res; 2001 Sep; 100(1):46-56. PubMed ID: 11516204
[TBL] [Abstract][Full Text] [Related]
11. In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2.
Ribatti D; Leali D; Vacca A; Giuliani R; Gualandris A; Roncali L; Nolli ML; Presta M
J Cell Sci; 1999 Dec; 112 ( Pt 23)():4213-21. PubMed ID: 10564640
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells.
Hamada Ji ; Omatsu T; Okada F; Furuuchi K; Okubo Y; Takahashi Y; Tada M; Miyazaki YJ; Taniguchi Y; Shirato H; Miyasaka K; Moriuchi T
Int J Cancer; 2001 Aug; 93(4):516-25. PubMed ID: 11477555
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of integrin beta 3 expression by cyclic stretch in human umbilical endothelial cells.
Suzuki M; Naruse K; Asano Y; Okamoto T; Nishikimi N; Sakurai T; Nimura Y; Sokabe M
Biochem Biophys Res Commun; 1997 Oct; 239(2):372-6. PubMed ID: 9344837
[TBL] [Abstract][Full Text] [Related]
14. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM
Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.
Gualandris A; Rusnati M; Belleri M; Nelli EE; Bastaki M; Molinari-Tosatti MP; Bonardi F; Parolini S; Albini A; Morbidelli L; Ziche M; Corallini A; Possati L; Vacca A; Ribatti D; Presta M
Cell Growth Differ; 1996 Feb; 7(2):147-60. PubMed ID: 8822198
[TBL] [Abstract][Full Text] [Related]
16. Expression and modulation of homeobox genes from cluster B in endothelial cells.
Belotti D; Clausse N; Flagiello D; Alami Y; Daukandt M; Deroanne C; Malfoy B; Boncinelli E; Faiella A; Castronovo V
Lab Invest; 1998 Oct; 78(10):1291-9. PubMed ID: 9800955
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Gualandris A; Presta M
J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
[TBL] [Abstract][Full Text] [Related]
18. Human pituitary tumor-transforming gene induces angiogenesis.
Ishikawa H; Heaney AP; Yu R; Horwitz GA; Melmed S
J Clin Endocrinol Metab; 2001 Feb; 86(2):867-74. PubMed ID: 11158059
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
[TBL] [Abstract][Full Text] [Related]
20. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.
Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P
J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
